Related Experiment Video

Updated: Aug 18, 2026

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.6K

Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study

Zonne L M Hofman1, Chantal C Clark2, C Erik Hack3

  • 1Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands; Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

The Journal of Allergy and Clinical Immunology
|May 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

3.1K

Related Experiment Videos

Last Updated: Aug 18, 2026

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

3.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Generation and characterization of human iPSC line SANi013-A from a Diamond-Blackfan anemia syndrome (DBAS) patient carrying a heterozygous RPS26 c.95-98 duplication variant.

Stem cell research·2026

Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

mAbs·2026

Development of an anti-rat complement C2 antibody that improves renal outcome in a rat kidney transplant model.

Frontiers in immunology·2026

Intravenous lanadelumab for the treatment of moderately ill COVID-19 patients.

British journal of clinical pharmacology·2026

IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

Neurology(R) neuroimmunology & neuroinflammation·2025

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease.

Research and practice in thrombosis and haemostasis·2025

Early-Life Wheezing and Childhood Cognition in the ECHO Cohort.

The Journal of allergy and clinical immunology·2026

Tonsillar expression quantitative trait loci verify and expand genetic contributors to childhood atopic diseases.

The Journal of allergy and clinical immunology·2026

IL1A promotes inflammation while safeguarding epithelial basal cell identity and barrier function.

The Journal of allergy and clinical immunology·2026

Classroom Microbiome Signatures of Pest Management Associate with Reduced Asthma Symptoms.

The Journal of allergy and clinical immunology·2026

Context-Dependent Regulation of Mast Cell-Mediated Food Allergy in C57BL/6J Mice.

The Journal of allergy and clinical immunology·2026

SERPINB9 is associated with clinical improvement during aspirin therapy in aspirin-exacerbated respiratory disease.

The Journal of allergy and clinical immunology·2026

Elucidating PI3K/AKT/PTEN Pathway Alterations at Single-Cell Level in CTCs From HR+/HER2- Metastatic Breast Cancer.

Cancer science·2026

Nanomessenger-Mediated Signal Crosstalk Encodes Multithreading Death Program Against Tumor Metastasis.

Small (Weinheim an der Bergstrasse, Germany)·2026

Inhibition of chondroitin sulfate proteoglycans enhances cell migration following enteric neural stem cell transplantation.

Development (Cambridge, England)·2026

The UVA-induced single-base mutational signature of CX-5461 in human cells.

Nucleic acids research·2026

Effects of Ozone Therapy on the Bladder of Rats with Streptozocin-Induced Diabetes.

Drug design, development and therapy·2026

Clinical Evaluation of Anaplastic Lymphoma Kinase (ALK) Inhibitors for the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer Based on the 2nd Edition of China's Drug Evaluation and Selection Guideline.

Drug design, development and therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us